This article is part of the supplement: 1st Scientific Meeting of the Head and Neck Optical Diagnostics Society .

Oral presentation

Optical technologies for detection and diagnosis of oral neoplasia

Ann Gillenwater

Department of Head and Neck Surgery, UT M.D. Anderson Cancer Center, Texas, USA

corresponding author email

from 1^st Scientific Meeting of the Head and Neck Optical Diagnostics Society
London, UK. 14 March 2009

Head & Neck Oncology 2009, 1(Suppl 1):O11doi:10.1186/1758-3284-1-S1-O11

Published:	28 July 2009

First paragraph (this article has no abstract)

The goal of our research is to develop an approach to early detection and diagnosis of oral neoplasia using optical-based technologies such as fluorescence spectroscopy and imaging, high-resolution microendoscopy and molecularly-targeted optical contrast agents. Although patients with early disease have better chances for cure and functional outcome, most patients present with advanced tumours when treatment is less successful and often causes severe deficits in speech, swallowing, facial appearance and quality of life. To improve outcomes we must improve detection and diagnosis of early neoplastic changes. Changes in tissue architecture, morphology, and molecular composition that occur during carcinogenesis also produce changes in the optical properties of tissue. These changes can be detected non-invasively, in vivo, and in near real-time using optical spectroscopy and imaging. Our research group has developed multi-spectral imaging devices for wide field visualization of early changes in oral mucosa. We are investigating whether these devices can improve the clinician's ability 1) to improve visualization of early neoplastic changes in oral mucosa that can be difficult to see using normal white light examination in community settings, 2) to choose optimal sites within lesions to perform biopsies, and 3) to visualize the peripheral margins of disease. We have also shown that using computer algorithms and disease probability maps, optical imaging and spectroscopy can provide objective discrimination between normal and abnormal oral mucosa with good sensitivity and specificity – similar to that of oral cancer specialists. We are now developing simplified optical devices to use in screening and diagnosis in community settings.